P2.04-46 Tolerability and Treatment-Related Adverse Events of Upfront Pembrolizumab Combination Regimens in Advanced NSCLC Patients

Autor:	Jahan, N., Thein, K., Sultan, A., Swarup, S., Mogollon-Duffo, F., Adhikari, N., Arevalo, M., Htut, T., Naing, T., D’Cunha, N., Rehman, S., Hardwicke, F., Tijani, L.
Zdroj:	In Journal of Thoracic Oncology October 2019 14(10) Supplement:S726-S726
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu